Open Journal Systems

Cover Image

Meditation and Yoga can Modulate Brain Mechanisms that affect Behavior and Anxiety- A Modern Scientific Perspective

Divya Krishnakumar, Michael R Hamblin, Shanmugamurthy Lakshmanan

Abstract


Meditation and Yoga techniques are receiving increased attention throughout the world, due to the accumulation of evidence based research that proves the direct and indirect benefits of such practices. Based on studies conducted so far, it has been found that the practice of meditation triggers neurotransmitters that modulate psychological disorders such as anxiety. This paper will review the psychological effects of the practice of meditation, the role of neurotransmitters, and studies using EEG and fMRI.

 

Keywords


Meditation, Yoga, Neurotransmitters, brain mechanisms, Behaviour and Anxiety

Full Text:

PDF PDF Plus

References


Kessler RC, Chiu WT, Demler O, Walters EE: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of general psychiatry 2005, 62:617-627.

http://dx.doi.org/10.1001/archpsyc.62.6.617

http://dx.doi.org/10.1001/archpsyc.62.6.593

National Institute of Mental Health: Anxiety Disorders In Children and Adolescents. http://www.nimh.nih.gov/health/publications/teenage-brain-a-work-in-progress-factsheet/index.shtml.; 2015.

Association AP: Diagnostic and statistical manual of mental disorders, (DSM-5®): American Psychiatric Pub; 2013.

http://dx.doi.org/10.1176/appi.books.9780890425596

Bremner JD, Innis RB, White T, Fujita M, Silbersweig D, Goddard AW, Staib L, Stern E, Cappiello A, Woods S: SPECT [I-123] iomazenil measurement of the benzodiazepine receptor in panic disorder. Biological Psychiatry 2000, 47:96-106.

http://dx.doi.org/10.1016/S0006-3223(99)00188-2

Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ: Decreased brain GABAA-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Archives of General Psychiatry 1998, 55:715-720.

http://dx.doi.org/10.1001/archpsyc.55.8.715

Crestani F, Lorez M, Baer K, Essrich C, Benke D, Laurent JP, Belzung C, Fritschy J-M, Lüscher B, Mohler H: Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nature neuroscience 1999, 2:833-839.

http://dx.doi.org/10.1038/12207

Kosel M, Rudolph U, Wielepp P, Luginbuhl M, Schmitt W, Fisch HU, Schlaepfer TE: Diminished GABAA Receptor Binding Capacity and a DNA Base Substitution in a Patient with Treatment-Resistant Depression and Anxiety. Neuropsychopharmacology 2004, 29:1762-1762.

http://dx.doi.org/10.1038/sj.npp.1300448

http://dx.doi.org/10.1038/sj.npp.1300353

http://dx.doi.org/10.1038/sj.npp.1300447

Newberg AB, Iversen J: The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations. Medical hypotheses 2003, 61:282-291.

http://dx.doi.org/10.1016/S0306-9877(03)00175-0

Cornwall J, Phillipson O: Mediodorsal and reticular thalamic nuclei receive collateral axons from prefrontal cortex and laterodorsal tegmental nucleus in the rat. Neuroscience letters 1988, 88:121-126.

http://dx.doi.org/10.1016/0304-3940(88)90111-5

Destexhe A, Contreras D, Steriade M: Mechanisms underlying the synchronizing action of corticothalamic feedback through inhibition of thalamic relay cells. Journal of neurophysiology 1998, 79:999-1016.

Guglietti CL, Daskalakis ZJ, Radhu N, Fitzgerald PB, Ritvo P: Meditation-related increases in GABA B modulated cortical inhibition. Brain stimulation 2013, 6:397-402.

http://dx.doi.org/10.1016/j.brs.2012.08.005

Elias A, Guich S, Wilson A: Ketosis with enhanced GABAergic tone promotes physiological changes in transcendental meditation. Medical hypotheses 2000, 54:660-662.

http://dx.doi.org/10.1054/mehy.1999.0921

Kim J, Gorman J: The psychobiology of anxiety. Clinical Neuroscience Research 2005, 4:335-347.

http://dx.doi.org/10.1016/j.cnr.2005.03.008

Walton KG, Pugh ND, Gelderloos P, Macrae P: Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism. The journal of alternative and complementary medicine 1995, 1:263-283.

http://dx.doi.org/10.1089/acm.1995.1.263

Bujatti M, Biederer P: Serotonin, noradrenaline, dopamine metabolites in transcendental meditation-technique. Journal of Neural Transmission 1976, 39:257-267.

http://dx.doi.org/10.1007/BF01256514

Selden N, Robbins TW, Everitt B: Enhanced behavioral conditioning to context and impaired behavioral and neuroendocrine responses to conditioned stimuli following ceruleocortical noradrenergic lesions: support for an attentional hypothesis of central noradrenergic function. The Journal of Neuroscience 1990, 10:531-539.

Curiati JA, Bocchi E, Freire JO, Arantes AC, Braga M, Garcia Y, Guimarães G, Fo WJ: Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: a prospective randomized study. Journal of Alternative & Complementary Medicine 2005, 11:465-472.

http://dx.doi.org/10.1089/acm.2005.11.465

Infante JR, Torres-Avisbal M, Pinel P, Vallejo JA, Peran F, Gonzalez F, Contreras P, Pacheco C, Latre JMa, Roldan A: Catecholamine levels in practitioners of the transcendental meditation technique. Physiology & behavior 2001, 72:141-146.

http://dx.doi.org/10.1016/S0031-9384(00)00386-3

Schneier FR, Liebowitz MR, Abi-Dargham A, Zea-Ponce Y, Lin S-H, Laruelle M: Low dopamine D2 receptor binding potential in social phobia. American Journal of Psychiatry 2000, 157:457-459.

http://dx.doi.org/10.1176/appi.ajp.157.3.457

Kjaer TW, Bertelsen C, Piccini P, Brooks D, Alving J, Lou HC: Increased dopamine tone during meditation-induced change of consciousness. Cognitive Brain Research 2002, 13:255-259.

http://dx.doi.org/10.1016/S0926-6410(01)00106-9

Golombek DA, Martini M, Cardinali DP: Melatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic system. European journal of pharmacology 1993, 237:231-236.

http://dx.doi.org/10.1016/0014-2999(93)90273-K

Yousaf F, Seet E, Venkatraghavan L, Abrishami A, Chung F: Efficacy and safety of melatonin as an anxiolytic and analgesic in the perioperative period. Anesthesiology 2010, 113:968-976.

http://dx.doi.org/10.1097/ALN.0b013e3181e7d626

Tooley GA, Armstrong SM, Norman TR, Sali A: Acute increases in night-time plasma melatonin levels following a period of meditation. Biological Psychology 2000, 53:69-78.

http://dx.doi.org/10.1016/S0301-0511(00)00035-1

Ulett GA, Gleser G, Winokur G, Lawler A: The EEG and reaction to photic stimulation as an index of anxiety-proneness. Electroencephalography and clinical neurophysiology 1953, 5:23-32.

http://dx.doi.org/10.1016/0013-4694(53)90049-2

Hardt JV, Kamiya J: Anxiety change through electroencephalographic alpha feedback seen only in high anxiety subjects. Science 1978, 201:79-81.

http://dx.doi.org/10.1126/science.663641

Cahn BR, Polich J: Meditation states and traits: EEG, ERP, and neuroimaging studies. Psychological bulletin 2006, 132:180.

http://dx.doi.org/10.1037/0033-2909.132.2.180

Inanaga K: Frontal midline theta rhythm and mental activity. Psychiatry and Clinical Neurosciences 1998, 52:555-566.

http://dx.doi.org/10.1046/j.1440-1819.1998.00452.x

http://dx.doi.org/10.1111/j.1440-1819.1998.tb02700.x

Aftanas L, Golosheykin S: Impact of regular meditation practice on EEG activity at rest and during evoked negative emotions. International Journal of Neuroscience 2005, 115:893-909.

http://dx.doi.org/10.1080/00207450590897969

Lang AJ, Strauss JL, Bomyea J, Bormann JE, Hickman SD, Good RC, Essex M: The theoretical and empirical basis for meditation as an intervention for PTSD. Behavior modification 2012:0145445512441200.

http://dx.doi.org/10.1177/0145445512441200

Kimbrough E, Magyari T, Langenberg P, Chesney M, Berman B: Mindfulness intervention for child abuse survivors. Journal of clinical psychology 2010, 66:17-33.

Niles BL, Klunk-Gillis J, Ryngala DJ, Silberbogen AK, Paysnick A, Wolf EJ: Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychological Trauma: Theory, Research, Practice, and Policy 2012, 4:538.

http://dx.doi.org/10.1037/a0026161

Miller JJ, Fletcher K, Kabat-Zinn J: Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. General hospital psychiatry 1995, 17:192-200.

http://dx.doi.org/10.1016/0163-8343(95)00025-M

Peterson LG, Pbert L: Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry 1992, 149:936-943.

http://dx.doi.org/10.1176/ajp.149.7.936

Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD: Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Archives of general psychiatry 2009, 66:1361-1372.

http://dx.doi.org/10.1001/archgenpsychiatry.2009.104

Hölzel BK, Hoge EA, Greve DN, Gard T, Creswell JD, Brown KW, Barrett LF, Schwartz C, Vaitl D, Lazar SW: Neural mechanisms of symptom improvements in generalized anxiety disorder following mindfulness training. NeuroImage: Clinical 2013, 2:448-458.

Nidich SI, Rainforth MV, Haaga DA, Hagelin J, Salerno JW, Travis F, Tanner M, Gaylord-King C, Grosswald S, Schneider RH: A randomized controlled trial on effects of the Transcendental Meditation program on blood pressure, psychological distress, and coping in young adults. American journal of hypertension 2009, 22:1326-1331.

http://dx.doi.org/10.1038/ajh.2009.184

Bormann JE, Liu L, Thorp SR, Lang AJ: Spiritual wellbeing mediates PTSD change in veterans with military-related PTSD. International journal of behavioral medicine 2012, 19:496-502.

http://dx.doi.org/10.1007/s12529-011-9186-1

http://dx.doi.org/10.1007/s12529-011-9212-3

Morgan A: Sahaja Yoga: an ancient path to modern mental health? 1999.

Shannahoff-Khalsa DS, Beckett LR: Clinical Case Report: Efficacy of Yogic Techniques in the Treatment of Obsessive Compulsive D Isorders. International Journal of Neuroscience 1996, 85:1-17.

http://dx.doi.org/10.3109/00207459608986347




DOI: http://dx.doi.org/10.14259%2Fas.v2i1.171

Refbacks

  • There are currently no refbacks.